SCHEMBL19785165

SCHEMBL19785165

CCC(=O)CS(=O)(=O)NCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
CA12 O43570 5/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 3/20 0.52
CA14 Q9ULX7 3/20 0.52
CA1 P00915 3/20 0.50
ALDH1A1 P00352 1/20 0.47
KEAP1 Q14145 1/20 0.47
TSHR P16473 2/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47
CA9 Q16790 2/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9615080 0.82 CA12 (0.59) CA12CA2CA7CA14CA1
SCHEMBL2112943 0.80 CA2 (0.65) CA12CA2CA7CA14CA1
SCHEMBL24990193 0.75 CA2 (0.59) CA12CA2CA7CA14CA1
SCHEMBL813026 0.74 CA2 (0.68) CA12CA2CA7CA14CA1
SCHEMBL16477917 0.74 CA12 (0.68) CA12CA2CA7CA14CA1
SCHEMBL6534021 0.74 CA12 (0.68) CA12CA2CA7CA14CA1
SCHEMBL195152 0.72 CA2 (0.55) CA12CA2CA7CA14CA1
SCHEMBL13895320 0.72 CA2 (0.55) CA12CA2CA7CA14CA1
SCHEMBL12655103 0.72 SMN1; SMN2 (0.50) ALDH1A1KDM4ERECQLHTTKMT2A
SCHEMBL10317146 0.71 CA12 (0.53) CA12CA2CA7CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011163-A1 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE AND 6,7-DIHYDRO-4H-TRIAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2018-01-18 WO disclosed